Quarterly report pursuant to Section 13 or 15(d)

COMMITMENTS AND CONTINGENCIES (Details Narrative)

v3.22.2
COMMITMENTS AND CONTINGENCIES (Details Narrative)
3 Months Ended 6 Months Ended
Jun. 30, 2022
USD ($)
Jun. 30, 2022
USD ($)
May 26, 2022
USD ($)
Aug. 26, 2021
ft²
Commitments and Contingencies Disclosure [Abstract]        
Sublease Area | ft²       12,112
Sublease Area Total | ft²       30,023
Sublease Agreement Description   Effective August 26, 2021, the Company entered into a sublease agreement with a third party to sublease 12,112 square feet of the 30,023 square feet currently being leased under one of its two existing lease agreements. The sublease commenced on October 1, 2021 and ends October 31, 2026. The Company notes sublease income of $55,133 and $110,266 for the three and six months ended June 30, 2022, respectively was recognized and offset against rent expense.    
Subleases Income | $ $ 55,133 $ 110,266    
Settlement Of disputes with Venn Therapeutics, LLC | $     $ 5,000,000